The reported frequencies of MYC rearrangement in CNS DLBCL (3–8% in prior studies and 9% in our study) are slightly lower than those reported in systemic DLBCL (10–15%) [7]–[9], [13], [14]. This evidence concerns the gene MYC and diffuse large B-cell lymphoma of the central nervous system.